Shares of Aprea Therapeutics (APRE), a clinical-stage precision medicine oncology company, jumped just over 22% on Tuesday. This extended a 26% surge from the previous session In mid-afternoon trading, APRE sat at $0.98, a rise of 18 cents on the session
Shares of Aprea Therapeutics (APRE), a clinical-stage precision medicine oncology company, jumped just over 22% on Tuesday.
This extended a 26% surge from the previous session
In mid-afternoon trading, APRE sat at $0.98, a rise of 18 cents on the session
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
